All Eli Lilly articles

  • market-capitalisation
    News

    Biopharma sees strong Q2 2023 market cap growth

    2023-08-21T14:05:41Z

    Johnson & Johnson have been shifted from the top position in the market capitalisation ranking for the first time, due to Eli Lilly having the largest growth during Q2 2023, research shows.

  • empagliflozin
    News

    New CKD treatment option approved in EU

    2023-07-26T11:40:57Z

    The first SGLT2 inhibitor to demonstrate a statistically significant reduction in all-cause hospitalisations in chronic kidney disease (CKD) patients versus placebo has been approved in the EU.